Digital On collaboration, computational chemistry, and cutting-edge ... Dr Olga Nissan, vice president of business development at Evogene discusses collaboration with Google Cloud & generative design of small molecules.
Market Access Is AI the missing link in fixing MLR – or the reason it brea... Somewhere in a shared drive at a mid-size pharma company, there is a folder labelled “Q3 Messaging FINAL v3 (2).” Inside it are three Word documents with tracked changes from four people, n
Digital We can’t fix modern healthcare with 1950s solutions. AI is t... In today’s NHS, the urgency of embracing artificial intelligence (AI) is no longer a matter of innovation - it’s a matter of survival.
Patients Responding to global greying: Does Nordic AgeTech hold the b... It’s a fact of life that we’re all living longer, which is reshaping the way healthcare is delivered.
Digital What is the future of technology in health data? From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things.
Digital From pilots to impact: What it really takes to scale GenAI i... Just a year ago, the GenAI buzz in pharma felt like the start of a gold rush. Leaders greenlit pilots. Teams spun up proof-of-concepts.
News TransThera's resistant biliary cancer drug cleared in China TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.